GCP
BVS icon

GSA Capital Partners’s Bioventus BVS Stock Holding History

GSA Capital Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+25,217
New +$241K 0.02% 1440
2024
Q4 		– Sell
-58,832
Closed -$703K – 1630
2024
Q3 		$703K Buy
58,832
+27,132
+86% +$235K 0.05% 684
2024
Q2 		$182K Buy
+31,700
New +$174K 0.01% 1471
2022
Q1 		– Sell
-13,621
Closed -$197K – 1429
2021
Q4 		$197K Buy
+13,621
New +$194K 0.02% 1236

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GSA Capital Partners's BVS Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Bioventus (BVS) in Q2 2026: 25,217 shares worth $238K. The stake represents 0.02% of the portfolio and ranks #1440 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in BVS as recently as Q3 2024.

GSA Capital Partners first reported a position in BVS in Q4 2021 and has held it in 4 quarters since. The position peaked at $703K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • GSA Capital Partners held 25,217 shares of Bioventus worth $238K as of Q2 2026.
  • Bioventus was a new GSA Capital Partners position in Q2 2026.
  • Bioventus made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1440 holding.
  • GSA Capital Partners first reported a position in Bioventus in Q4 2021 and has held it in 4 quarters since.
  • GSA Capital Partners's Bioventus position peaked at $703K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.